HealthQuill UCSF
Lykos Therapeutics’s ecstasy drug or midomafetamine capsules for the treatment of post-traumatic stress disorder in adults was rejected by the US drug regulatory body, according to the company.
Drugs Health Pharma

US regulator rejects Lykos’s MDMA therapy, wants more data 

Lykos Therapeutics’s ecstasy drug or midomafetamine capsules for the treatment of post-traumatic stress disorder in adults was rejected by the US drug regulatory.

Read More
Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.
Drugs Health Pharma

Contineum’s test drug may reverse multiple sclerosis damage

Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.

Read More
Kidney cells placed in an implantable device in pigs can mimic several functions of the organ without triggering the recipient’s immune system to attack, scientists found.
Drugs Health Pharma

UCSF scientists mold a ‘bioreactor’ to replace dialysis

HQ Team September 2, 2023: Kidney cells placed in an implantable device in pigs can mimic several functions of the organ without triggering.

Read More